DOW JONES27,960.80-1031.61 -3.56%
S&P 5003,225.89-111.86 -3.35%
NASDAQ9,221.28-355.31 -3.71%

Intercept Reports Completion Of Enrollment For Phase 3 REVERSE Study Evaluating Obeticholic Acid For Treatment Of Compensated Cirrhosis Due To NASH

Benzinga · 01/29/2020 13:04